Preclinical and Clinical Advances of Targeted Protein Degradation as a Novel Cancer Therapeutic Strategy: An Oncologist Perspective Xinrui YangHe YinHao Xie Review Article 28 December 2020 Pages: 1 - 12
Prognostic Value of Soluble Programmed Cell Death Ligand-1 (sPD-L1) in Various Cancers: A Meta-analysis Xiaoyang LiYu ZhengFei Yue Original Research Article 22 November 2020 Pages: 13 - 26
Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib Nicola FazioMatthew KulkeEric Raymond Original Research Article Open access 07 January 2021 Pages: 27 - 35
Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors Jean-Pierre DelordAntoine ItalianoEric Raymond Original Research Article 10 November 2020 Pages: 37 - 46
Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial Céleste LebbéAntoine ItalianoJean-Pierre Delord Original Research Article 19 November 2020 Pages: 47 - 57
Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile Domenica LorussoGiuseppa MalteseFilippo de Braud Original Research Article Open access 28 December 2020 Pages: 59 - 68
Impact of Dose Reduction on Efficacy: Implications of Exposure-Response Analysis of Palbociclib Jenny ZhengYanke YuDiane D. Wang Original Research Article Open access 19 November 2020 Pages: 69 - 76
The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib Anna BuderMaximilian J. HochmairMartin Filipits Original Research Article Open access 03 December 2020 Pages: 77 - 84
Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA François LalibertéMonika RautMei Sheng Duh Original Research Article Open access 07 December 2020 Pages: 85 - 94
Developing Symptom Lists for People with Cancer Treated with Targeted Therapies Samantha C. SodergrenSally J. Wheelwrightthe EORTC Quality of Life Group Original Research Article 09 November 2020 Pages: 95 - 107
Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers Catherine H. WatsonGloria BroadwaterRebecca A. Previs Original Research Article 05 January 2021 Pages: 109 - 118
Correction to: SB8: A Bevacizumab Biosimilar Yahiya Y. Syed Correction Open access 11 December 2020 Pages: 119 - 119